For: | Gato S, Lucena-Valera A, Muñoz-Hernández R, Sousa JM, Romero-Gómez M, Ampuero J. Impact of COVID-19 on liver disease: From the experimental to the clinic perspective. World J Virol 2021; 10(6): 301-311 [PMID: 34909404 DOI: 10.5501/wjv.v10.i6.301] |
---|---|
URL: | https://www.wjgnet.com/2220-3249/full/v10/i6/301.htm |
Number | Citing Articles |
1 |
Juan Carlos Restrepo-Gutiérrez, Ana Isabel Toro-Montoya. Enfermedad hepatobiliar asociada a COVID-19. Hepatología 2022; : 143 doi: 10.52784/27112330.155
|
2 |
Agata Michalak, Tomasz Lach, Karolina Szczygieł, Halina Cichoż-Lach. COVID-19, Possible Hepatic Pathways and Alcohol Abuse—What Do We Know up to 2023?. International Journal of Molecular Sciences 2024; 25(4): 2212 doi: 10.3390/ijms25042212
|
3 |
Carla Sousa da Silva, Katrini Guidolini Martinelli, Marlison Wesley Miranda Viana, Deliane dos Santos Soares, Yasmin Garcia Silva Corrêa, Lucas Lima da Silva, Vanessa Salete de Paula, Luana Lorena Silva Rodrigues, Livia Melo Villar. Liver and Inflammatory Biomarkers Are Related to High Mortality in Hospitalized Patients with COVID-19 in Brazilian Amazon Region. Life 2024; 14(7): 869 doi: 10.3390/life14070869
|
4 |
Ana Pereira, Diana Lima, Mariana Martins, Teresa Plancha-Silva, Marta Amaral-Silva, Elsa Marques. Idiopathic Scoliosis Trends One Year After COVID-19: A Retrospective Study. Cureus 2022; doi: 10.7759/cureus.32779
|
5 |
Ana Lucena Valera, Rocío Aller dela Fuente, Yolanda Sánchez Torrijos, Manuel Romero Gómez, Javier Ampuero Herrojo. FIB-4 Score as Predictor of COVID-19-related Severity in hospitalized patients. Revista Española de Enfermedades Digestivas 2024; doi: 10.17235/reed.2024.9811/2023
|